APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $79,000 | +49.1% | 2,556 | +15.9% | 0.00% | – |
Q3 2019 | $53,000 | +60.6% | 2,206 | +69.7% | 0.00% | – |
Q2 2019 | $33,000 | +230.0% | 1,300 | +160.0% | 0.00% | – |
Q1 2019 | $10,000 | +42.9% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -22.2% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |